Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Pastan

Showing results (651-660 of 689) with videos related to

Pageof 69
Sort By:
The Journal of Biological Chemistry|January 5, 1990
Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 proteaseA G Tomasselli, J O Hui, T K Sawyer, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1997
Factors influencing the in vivo pharmacokinetics of peptides and antibody fragments: the pharmacokinetics of two PET-labeled low molecular weight proteinsL Lang, E Jagoda, C Wu, et al.
Journal of Cellular Physiology|July 1, 1992
Reduced mRNA levels for the multidrug-resistance genes in cAMP-dependent protein kinase mutant cell linesK V Chin, S S Chauhan, I Abraham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivoD Yang, C T Kuan, J Payne, et al.
Bioconjugate Chemistry|May 29, 1999
Chemical modification to reduce renal uptake of disulfide-bonded variable region fragment of anti-Tac monoclonal antibody labeled with 99mTcI S Kim, T M Yoo, H Kobayashi, et al.
Nature|June 4, 1984
Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cellsY H Xu, S Ishii, A J Clark, et al.
Infection and Immunity|March 1, 1993
Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein AA Fattom, R Schneerson, D C Watson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1986
Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cellsI B Roninson, J E Chin, K G Choi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 1999
Methods to avoid adverse effect of circulating antigen on biodistribution of 125I-labeled antiTac dsFv: preinjection of intact antibody versus clearance of antigen with adivin-biotin systemH Kobayashi, B F Sun, T M Yoo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2000
Pharmacokinetics of 111In- and 125I-labeled antiTac single-chain Fv recombinant immunotoxinH Kobayashi, C H Kao, R J Kreitman, et al.
Pageof 69

Showing results (651-660 of 689) with videos related to

Sort By:
Pageof 69
The Journal of Biological Chemistry|January 5, 1990
Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 proteaseA G Tomasselli, J O Hui, T K Sawyer, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1997
Factors influencing the in vivo pharmacokinetics of peptides and antibody fragments: the pharmacokinetics of two PET-labeled low molecular weight proteinsL Lang, E Jagoda, C Wu, et al.
Journal of Cellular Physiology|July 1, 1992
Reduced mRNA levels for the multidrug-resistance genes in cAMP-dependent protein kinase mutant cell linesK V Chin, S S Chauhan, I Abraham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivoD Yang, C T Kuan, J Payne, et al.
Bioconjugate Chemistry|May 29, 1999
Chemical modification to reduce renal uptake of disulfide-bonded variable region fragment of anti-Tac monoclonal antibody labeled with 99mTcI S Kim, T M Yoo, H Kobayashi, et al.
Nature|June 4, 1984
Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cellsY H Xu, S Ishii, A J Clark, et al.
Infection and Immunity|March 1, 1993
Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein AA Fattom, R Schneerson, D C Watson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1986
Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cellsI B Roninson, J E Chin, K G Choi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 1999
Methods to avoid adverse effect of circulating antigen on biodistribution of 125I-labeled antiTac dsFv: preinjection of intact antibody versus clearance of antigen with adivin-biotin systemH Kobayashi, B F Sun, T M Yoo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2000
Pharmacokinetics of 111In- and 125I-labeled antiTac single-chain Fv recombinant immunotoxinH Kobayashi, C H Kao, R J Kreitman, et al.
Pageof 69